ABT:NYSEAbbott Laboratories Analysis

The moving-average structure behind Abbott Laboratories is neutral at $110.36, with no clear ordering between short and long averages. The last 30 days have gained 8.6%. RSI sits at 52.9, which reads as neutral, and MACD momentum is bearish. Watch $104.20 as support and $117.34 as the nearer resistance level.
Multiples put this in fair territory: 36.4 times earnings against the sector's 30.4. Analyst price targets sit 8.9% above the current price. Revenue is growing at 13.0% on a 11.6% profit margin. The 2.28% dividend yield looks covered by current payout levels.
The composite risk read is 4/10, putting it in moderate territory. With 30-day volatility of 22.5%, a beta of 0.03 and a maximum drawdown of 39.6%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.